Effect of Western medicine therapy assisted by Ginkgo biloba tablet on vascular cognitive impairment of none dementia

Asian Pacific Journal of Tropical Medicine

Volumn 5, Issue 8, 2012, Pages 661-664

  Zhang, Shi Jin ^a   Xue, Zhan You ^b  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Clinical evaluation; Cognitive impairment; Combination of traditional Chinese and Western medicine; Ginkgo tablet

Indexed keywords

ACETYLSALICYLIC ACID; GINKGO BILOBA EXTRACT; TANAKAN EGB 761; UNCLASSIFIED DRUG;

ADULT; AGED; ANTERIOR CEREBRAL ARTERY; ARTICLE; ATTENTION; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG EFFECT; DRUG EFFICACY; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MONOTHERAPY; MONTREAL COGNITIVE ASSESSMENT; ORIENTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TABLET; TREATMENT DURATION; VASCULAR COGNITIVE IMPAIRMENT OF NONE DEMENTIA;

AGED; ASPIRIN; BLOOD FLOW VELOCITY; CARDIOVASCULAR AGENTS; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PLANT EXTRACTS; PLATELET AGGREGATION INHIBITORS; PSYCHOLOGICAL TESTS; TREATMENT OUTCOME;

EID: 84864314584     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(12)60135-7     Document Type: Article

References (21)

1. Li J, Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 2011, 76(17):1485-1491.
2. Black SE Therapeutic issues in vascular dementia: studies, designs and approaches. Can J Neurol Sci 2007, 34(Suppl 1):S125-S130.
3. Dong Y, Sharma VK, Chan BP, Venketasubramanian N, Teoh HL, Seet RC, et al. The Montreal cognitive assessment (MoCA) is superior to the mini-mental state examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurol Sci 2010, 299(1-2):15-18.
4. Doruk H, Naharci MI, Bozoglu E, Isik AT, Kilic S The relationship between body mass index and incidental mild cognitive impairment, Alzheimer's disease and vascular dementia in elderly. J Nutr Health Aging 2010, 14(10):834-848.
5. Xie XW, Wang YL, He JG, Han JL Clinical observation on acute cerebral infarction treated with ginkgo leaf tablet and 1,6fibrin degradation products. Chin J Integr Trad & Western Med Intensive & Crit Care 1997, 6:21-22.
6. Birks J, Grimley Evans J Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 2007, 18(2):CD003120.
7. Battistin L, Cagnin A Vascular cognitive disorder. A biological and clinical overview. Neurochem Res 2010, 35(12):1933-1938.
8. Cumming T, Brodtmann A Dementia and stroke: the present and future epidemic. Int J Stroke 2010, 5(6):453-454.
9. Ferrer I Cognitive impairment of vascular origin: neuropathology of cognitive impairment of vascular origin. J Neurol Sci 2010, 299(1-2):139-149.
10. Stephan BC, Matthews FE, Khaw KT, Dufouil C, Brayne C Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND). Zheimers Res Ther 2009, 1(1):4.
11. Konsztowicz S, Xie H, Higgins J, Mayo N, Koski L Development of a method for quantifying cognitive ability in the elderly through adaptive test administration. Int Psychogeriatr 2011, 23(7):1116-1123.
12. Price CC, Cunningham H, Coronado N, Freedland A, Cosentino S, Penney DL, et al. Clock drawing in the Montreal cognitive assessment: recommendations for dementia assessment. Dement Geriatr Cogn Disord 2011, 31(3):179-187.
13. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53(4):695-699.
14. Sweet L, Van Adel M, Metcalf V, Wright L, Harley A, Leiva R, et al. The Montreal cognitive assessment (MoCA) in geriatric rehabilitation: psychometric properties and association with rehabilitation outcomes. Int Psychogeriatr 2011, 1:1-10.
15. Purandare N, Burns A, Daly KJ, Hardicre J, Morris J, Macfarlane G, et al. Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: case-control study. BMJ 2006, 332(7550):1119-1124.
16. Demarin V, Kes VB, Morović S, Zavoreo I Evaluation of aging vs. dementia by means of neurosonology. J Neurol Sci 2009, 283(1-2):9-12.
17. Silvestrini M, Pasqualetti P, Baruffaldi R, Bartolini M, Handouk Y, Matteis M, et al. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke 2006, 37(4):1010-1015.
18. Van H, Poommipanit P, Shalaby M, Gevorgyan R, Tseng CH, Tobis J Sensitivity of transcranial Doppler versus intracardiac echocardiography in the detection of right-to-left shunt. JACC Cardiovasc Imaging 2010, 3(4):343-348.
19. DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008, 300(19):2253-2262.
20. Gertz HJ, Kiefer M Review about Ginkgo biloba special extract EGb 761 (Ginkgo). Curr Pharm Des 2004, 10(3):261-264.
21. Birks J, Grimley EV, Van Dongen M Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 2002, (4):CD003120.